ALKEM - INDIA?S GENERIC & SPECIALITY PHARMACEUTICAL FORERUNNER
About Alkem 
A single idea, which sprouts from a human mind, contains the potential to create marvels that can influence generations. It can redefine rules, it can transform the world. Back in the year 1973, a team of individuals came with such an idea ? The idea called Alkem. It was highly potent and resilient, like a spark that could ignite a thousand more ideas. And it did!
Looking back at our 5 decade, illustrious journey, that one small idea has Not only triggered us to become one of India?s largest generic and specialty pharmaceutical company but also, create a foothold in over 40 countries
29% of our revenue is generated via offshore sales. As well as we have consistently been ranked amongst the top ten pharmaceutical companies in India. Our portfolio includes illustrious brands like Clavam, Pan, Pan-D and Taxim-O, which feature amongst top 50 pharmaceutical brands in India. For over a decade, our dominance in anti-infective segment has remained unchallenged.
We have 20 manufacturing facilities at multiple locations in India and the United States of America. Our upper-crest facilities are inspected and audited as per cGMP guidelines as laid down by leading regulatory authorities such as USFDA, MHRA - UK, SAHPRA-South Africa, TGA - Australia, ANVISA - Brazil, WHO - Geneva, TPD - Health Canada, PPB - Kenya, NDA - Uganda, MOH - Sudan, INVIMA - Colombia, TFDA - Tanzania, Zimbabwe, BfArM-Germany & Other Africa, Asian & CIS Countries.
Another feather in our cap was added on December 23rd, 2015, when, Alkem completed its Initial Public Offering (IPO) and was listed on the Bombay Stock Exchange Limited and the National Stock Exchange of India Limited.
Although, passion is the fuel that keeps ideas alive, innovation is the catalyst that gives it flight! With over 500 scientists working in 5 R&D centers, we are empowering innovations that align with our philosophy of ?Extended Lifecare Beyond Boundaries?.
HELPING BUILD THE NAME ? ALKEM
20 Manufacturing units
Over 800 brands
Business footprint in over 40 countries
A 21,000 plus strong workforce
Subsidiaries
Consolidated revenue Rs 115,993/- Million in FY 2022-23
HELPING BUILD THE NAME ? ALKEM
20 Manufacturing units
Over 800 brands
Business footprint in over 40 countries
A 21,000 plus strong workforce
Subsidiaries
Consolidated revenue Rs 115,993/- Million in FY 2022-23
S & B Holdings B.V., Netherlands
Wholly Owned Subsidiary
ThePharmaNetwork, LLC, USA (TPN)
Wholly Owned Subsidiary
Ascend Laboratories LLC, USA
Wholly Owned Subsidiary of TPN
S & B Pharma LLC
Wholly Owned Subsidiary of TPN
Pharmacor Pty Limited, Australia
Wholly Owned Subsidiary
Enzene Biosciences Ltd, India
Subsidiary
Ascend Laboratories (PTY) Ltd,
South Africa
Wholly Owned Subsidiary
Cachet Pharmaceuticals Pvt Ltd, India
Subsidiary
Indchemie Health Specialities Pvt Ltd, India
Subsidiary
Corporation, Philippines
Wholly Owned Subsidiary
Ascend GmbH, Germany
Wholly Owned Subsidiary
Ascend Laboratories SDN BHD., Malaysia
Wholly Owned Subsidiary
Ascend Laboratories SpA, Chile (Ascend Chile)
Wholly Owned Subsidiary
Pharma Network SpA, Chile
Wholly Owned Subsidiary of
Ascend Chile
Ascend Laboratories S.A. DE C.V., Mexico
Wholly Owned Subsidiary of
Ascend Chile
Korea Inc, Korea
Wholly Owned Subsidiary
Pharmacor Ltd., Kenya
Wholly Owned Subsidiary
The Pharma Network, LLP, Kazakhstan
Wholly Owned Subsidiary
Ascend Laboratories (UK) Ltd., UK
Wholly Owned Subsidiary
Ascend Laboratories Ltd., Canada
Wholly Owned Subsidiary
Alkem Foundation, India
Wholly Owned Subsidiary
Connect 2 Clinic Private Limited, India
Wholly Owned Subsidiary
Ascend Laboratories S.A.S, Colombia
Wholly Owned Subsidiary
Pharmacor Limited, New Zealand
Wholly Owned Subsidiary of
Pharmacor Pty Limited, Australia
Enzene Inc., USA
Wholly Owned Subsidiary of Enzene Biosciences Ltd, Indi

Alkem Laboratories Ltd is a multinational pharmaceutical company headquartered in Mumbai, Maharashtra that manufactures and sells pharmaceutical generics, formulations and nutraceuticals